Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

These may not only appeal to more people, avoiding the need for weekly injections, but are also likely to benefit patients who have a wide range of medical conditions ... doctors have said. The new ...

The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease.

Welcome to the Loss, Trauma, and Emotion Lab, headed by Professor George A Bonanno. Our offices are housed in the Department of Counseling and Clinical Psychology, Teachers College, Columbia ...

Iran united militias to take on Israel, but as the Israelis pummel one, Hezbollah, the rest have so far largely failed to come to its aid. By Ben Hubbard and Alissa J. Rubin The United States ...